NO20030059D0 - Tidlig diagnose av konformasjonssykdommer - Google Patents

Tidlig diagnose av konformasjonssykdommer

Info

Publication number
NO20030059D0
NO20030059D0 NO20030059A NO20030059A NO20030059D0 NO 20030059 D0 NO20030059 D0 NO 20030059D0 NO 20030059 A NO20030059 A NO 20030059A NO 20030059 A NO20030059 A NO 20030059A NO 20030059 D0 NO20030059 D0 NO 20030059D0
Authority
NO
Norway
Prior art keywords
early diagnosis
conformational diseases
conformational
diseases
diagnosis
Prior art date
Application number
NO20030059A
Other languages
English (en)
Other versions
NO20030059L (no
NO331624B1 (no
Inventor
Claudio Soto
Gabriella Saborio
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20030059D0 publication Critical patent/NO20030059D0/no
Publication of NO20030059L publication Critical patent/NO20030059L/no
Publication of NO331624B1 publication Critical patent/NO331624B1/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20030059A 2000-07-07 2003-01-06 Fremgangsmate for diagnostiseringen eller pavisningen av en konformasjonssykdom i en prove, test av en markor for en konformasjonssykdom, diagnostisk sett for anvendelse i testen, fremgangsmate for identifisering av forbindelse som modulerer konformasjonstransisjonen for protein, fremgangsmate for pavisning av patogen form av prionprotein, apparat for anvendelse i fremgangsmatene og fremgangsmate for diagnostisering av CJD og Alzheimers i en prove. NO331624B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP00114650 2000-07-07
EP00127892 2000-12-20
EP01102732 2001-02-07
PCT/GB2001/002584 WO2002004954A2 (en) 2000-07-07 2001-06-13 Early diagnosis of conformational diseases

Publications (3)

Publication Number Publication Date
NO20030059D0 true NO20030059D0 (no) 2003-01-06
NO20030059L NO20030059L (no) 2003-03-07
NO331624B1 NO331624B1 (no) 2012-02-06

Family

ID=27223071

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030059A NO331624B1 (no) 2000-07-07 2003-01-06 Fremgangsmate for diagnostiseringen eller pavisningen av en konformasjonssykdom i en prove, test av en markor for en konformasjonssykdom, diagnostisk sett for anvendelse i testen, fremgangsmate for identifisering av forbindelse som modulerer konformasjonstransisjonen for protein, fremgangsmate for pavisning av patogen form av prionprotein, apparat for anvendelse i fremgangsmatene og fremgangsmate for diagnostisering av CJD og Alzheimers i en prove.

Country Status (31)

Country Link
US (1) US7351526B2 (no)
EP (2) EP1712920B1 (no)
JP (1) JP4790966B2 (no)
KR (1) KR100764981B1 (no)
CN (1) CN1221807C (no)
AR (1) AR029583A1 (no)
AT (2) ATE426816T1 (no)
AU (2) AU2001264089B2 (no)
BG (1) BG66272B1 (no)
BR (1) BRPI0112262B8 (no)
CA (1) CA2413078C (no)
CY (1) CY1109106T1 (no)
CZ (1) CZ304365B6 (no)
DE (2) DE60138146D1 (no)
DK (2) DK1712920T3 (no)
EA (1) EA007391B1 (no)
EE (1) EE05675B1 (no)
ES (2) ES2322660T3 (no)
HK (1) HK1058065A1 (no)
HR (1) HRP20030033B1 (no)
HU (1) HU228813B1 (no)
IL (2) IL153824A0 (no)
MX (1) MXPA03000226A (no)
NO (1) NO331624B1 (no)
NZ (1) NZ523213A (no)
PL (1) PL211154B1 (no)
PT (2) PT1712920E (no)
RS (1) RS51523B (no)
SI (2) SI1299729T1 (no)
SK (1) SK287768B6 (no)
WO (1) WO2002004954A2 (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002073210A1 (de) * 2001-03-13 2002-09-19 Manfred Eigen Verfahren zur verstärkung der bildung von aggregaten aus proteinuntereinheiten
JP4235544B2 (ja) 2001-05-31 2009-03-11 アドライフ インコーポレーティッド 欠陥折畳み蛋白質センサー方法
US20050026165A1 (en) 2001-05-31 2005-02-03 Cindy Orser Detection of conformationally altered proteins and prions
CA2525517C (en) 2003-06-19 2016-05-31 Applied Research Systems Ars Holding N.V. Use of prion conversion modulating agents
DE10328125A1 (de) * 2003-06-23 2005-01-13 Roche Diagnostics Gmbh Nachweis von Protease-resistentem Prion-Protein nach spontaner Transformationsreaktion
DE10328830A1 (de) * 2003-06-26 2005-01-20 Roche Diagnostics Gmbh Nachweis von Protease-resistentem Prion-Protein nach asymmetrischer Interaktion
US20070054322A1 (en) * 2003-07-31 2007-03-08 Hadasit Medical Research Services & Development Lt Methods and kits for the detection of prion diseases
EP1653844B1 (en) 2003-08-13 2012-12-12 Novartis Vaccines and Diagnostics, Inc. Prion-specific peptide reagents
US20060057671A1 (en) * 2004-09-10 2006-03-16 Orser Cindy S Immobilized probes and methods of detecting conformationally altered prion proteins
JP4568840B2 (ja) * 2004-12-28 2010-10-27 国立大学法人金沢大学 アルツハイマー病の検査方法
WO2006088823A2 (en) * 2005-02-15 2006-08-24 Adlyfe, Inc. Method for detecting misfolded proteins and prions
WO2006113915A2 (en) * 2005-04-20 2006-10-26 Board Of Regents, The University Of Texas System Ultrasensitive detection of prions by automated protein misfolding cyclic amplification
EP1731911A1 (fr) 2005-06-07 2006-12-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Procédé utile pour la détection d'encéphalopathies
DE102005031429A1 (de) * 2005-07-04 2007-01-11 Heinrich-Heine-Universität Düsseldorf Verfahren zur selektiven Bestimmung pathologischer Proteinablagerungen
CA2621767A1 (en) 2005-09-09 2007-03-15 Novartis Ag Prion-specific peptoid reagents
US20070281367A1 (en) 2006-05-03 2007-12-06 Applera Corporation Methods, Compositions, and Kits for Quantitating Antibodies
WO2008013859A2 (en) * 2006-07-28 2008-01-31 Adlyfe, Inc. Peptide probes for diagnostics and therapeutics
EP2074222A4 (en) * 2006-09-06 2010-03-03 Univ Texas METHODS AND COMPOSITIONS FOR DETECTION OF PROTEIN FOLDING DISORDERS
EP2554996B1 (en) * 2007-07-20 2016-04-06 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Detection of infectious prion protein by seeded conversion of recombinant prion protein
FR2929290B1 (fr) * 2008-03-27 2010-05-07 Lfb Biotechnologies Methode de detection et/ou de titrage in vitro d'un agent transmissible non conventionnel
US20110124843A1 (en) 2008-05-28 2011-05-26 Incorporated Administrative Agency National Agriculture And Food Research Organization Method for efficiently amplifying abnormal prion protein derived from bse
JP5209711B2 (ja) 2008-05-28 2013-06-12 独立行政法人農業・食品産業技術総合研究機構 羊スクレイピー由来異常プリオン蛋白質の効率的増幅方法
ITMI20081052A1 (it) * 2008-06-10 2009-12-11 Univ Milano Bicocca Liposomi in grado di legare efficacemente il peptide beta-amiloide
FR2935711A1 (fr) * 2008-09-05 2010-03-12 Lfb Biotechnologies Clone cellulaire stable exprimant un prion
JP2013510297A (ja) * 2009-11-04 2013-03-21 ノバルティス アーゲー モノマーからのタンパク質凝集体の分離における結合試薬としての正に荷電した種
US10989718B2 (en) 2014-09-11 2021-04-27 Amprion, Inc. Detection of misfolded alpha synuclein protein
US10215763B2 (en) * 2010-05-18 2019-02-26 Board Of Regents Of The University Of Texas System Methods for estimating prion concentration in fluids and tissue by quantitative PMCA
IT1405762B1 (it) 2010-11-25 2014-01-24 Icgeb Proteine ricombinanti con attivita' di inattivazione selettiva di proteine bersaglio
CA2824863A1 (en) * 2011-01-18 2012-07-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for amplification and detection of prions
FR2973114A1 (fr) 2011-03-21 2012-09-28 Ets Francais Du Sang Nanobilles recouvertes de plasminogene comme support direct d'amplification cyclique de la proteine prion prpsc
WO2013056841A1 (en) 2011-10-19 2013-04-25 Inra (Institut National De La Recherche Agronomique) A method for diagnosing tse
KR101483438B1 (ko) * 2014-04-17 2015-01-16 한림대학교 산학협력단 극미량 병원성 프리온 단백질 검출방법 및 장치
WO2016040903A1 (en) 2014-09-11 2016-03-17 Board Of Regents Of The University Of Texas System Detection of misfolded amyloid beta protein
MX2017003269A (es) 2014-09-11 2017-12-04 Univ Texas Detección de las proteínas mal plegadas.
US10359434B2 (en) 2014-10-22 2019-07-23 Colorado State University Research Foundation In vitro detection of prions in blood
WO2016149537A1 (en) 2015-03-17 2016-09-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Bank vole prion protein as a broad-spectrum substrate for rt-quic-based detection and discrimination of prion strains
EP3635393A4 (en) 2017-05-16 2021-03-10 Claudio Soto-Jara DETECTION OF MISFOLDED TAU PROTEIN
US20190353669A1 (en) * 2018-05-16 2019-11-21 Amprion, Inc. Detection of Brain Injury or Neurological Disease using Tau Protein
US11598783B1 (en) 2019-10-23 2023-03-07 Colorado State University Research Foundation In vitro detection of prions
WO2021198098A1 (en) 2020-04-03 2021-10-07 Universität Zürich Improved method of detecting biomarkers in a biological sample

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262332A (en) * 1989-04-05 1993-11-16 Brigham And Women's Hospital Diagnostic method for Alzheimer's disease: examination of non-neural tissue
US5616871A (en) * 1995-09-28 1997-04-01 Drummond Scientific Company Pipet gun assembly
US5750361A (en) * 1995-11-02 1998-05-12 The Regents Of The University Of California Formation and use of prion protein (PRP) complexes
CA2268904A1 (en) * 1996-10-15 1998-04-23 Imperial College Of Science, Technology And Medicine Diagnosis of spongiform encephalopathy
EP1210110A4 (en) * 1999-06-29 2003-03-19 Univ Mcgill PROTEINS BINDING TO PRION PROTEIN AND THEIR USE
CA2393607A1 (en) * 1999-12-10 2001-06-28 Ronald R. Manna Ultrasonic horn assembly
WO2006113915A2 (en) * 2005-04-20 2006-10-26 Board Of Regents, The University Of Texas System Ultrasensitive detection of prions by automated protein misfolding cyclic amplification

Also Published As

Publication number Publication date
BRPI0112262B8 (pt) 2021-07-27
BR0112262A (pt) 2003-05-20
HK1058065A1 (en) 2004-04-30
DE60121958T2 (de) 2007-02-01
HUP0301020A2 (hu) 2003-07-28
CZ200336A3 (cs) 2003-06-18
SK18582002A3 (sk) 2003-05-02
DK1712920T3 (da) 2009-05-11
WO2002004954A3 (en) 2002-10-24
US7351526B2 (en) 2008-04-01
KR100764981B1 (ko) 2007-10-09
DE60138146D1 (de) 2009-05-07
ATE426816T1 (de) 2009-04-15
PT1712920E (pt) 2009-04-09
ES2322660T3 (es) 2009-06-24
IL153824A0 (en) 2003-07-31
KR20030036257A (ko) 2003-05-09
NZ523213A (en) 2005-01-28
MXPA03000226A (es) 2004-05-21
HU228813B1 (en) 2013-05-28
YU101202A (sh) 2006-01-16
CY1109106T1 (el) 2014-07-02
ES2264691T3 (es) 2007-01-16
EE200300005A (et) 2004-08-16
CN1221807C (zh) 2005-10-05
AR029583A1 (es) 2003-07-02
BG66272B1 (bg) 2012-11-30
ATE335204T1 (de) 2006-08-15
DE60121958D1 (de) 2006-09-14
RS51523B (sr) 2011-06-30
BRPI0112262B1 (pt) 2016-08-09
EA007391B1 (ru) 2006-10-27
JP2004503748A (ja) 2004-02-05
HUP0301020A3 (en) 2010-03-29
SI1712920T1 (sl) 2009-10-31
CN1449497A (zh) 2003-10-15
AU2001264089B2 (en) 2006-03-30
WO2002004954A2 (en) 2002-01-17
SI1299729T1 (sl) 2006-10-31
CA2413078C (en) 2010-08-03
NO20030059L (no) 2003-03-07
EE05675B1 (et) 2013-08-15
EP1299729A2 (en) 2003-04-09
DK1299729T3 (da) 2006-12-04
PL360397A1 (en) 2004-09-06
IL153824A (en) 2010-02-17
SK287768B6 (sk) 2011-09-05
PL211154B1 (pl) 2012-04-30
EP1712920B1 (en) 2009-03-25
JP4790966B2 (ja) 2011-10-12
EA200300126A1 (ru) 2003-06-26
HRP20030033B1 (en) 2008-04-30
EP1299729B1 (en) 2006-08-02
PT1299729E (pt) 2006-10-31
CZ304365B6 (cs) 2014-04-02
US20050064505A1 (en) 2005-03-24
HRP20030033A2 (en) 2004-02-29
EP1712920A1 (en) 2006-10-18
BG107498A (bg) 2003-11-28
CA2413078A1 (en) 2002-01-17
NO331624B1 (no) 2012-02-06
AU6408901A (en) 2002-01-21

Similar Documents

Publication Publication Date Title
NO20030059D0 (no) Tidlig diagnose av konformasjonssykdommer
DE60141752D1 (de) Differentielle diagnose von neurologischen krankheiten
NO20034855D0 (no) Behandling og diagnose av makrofagmediert sykdom
NO20021963D0 (no) Anvendelse av organiske forbindelser av sykdom
NO20031442L (no) Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer
NO20022592L (no) Forbindelser og fremgangsmåter for behandling og diagnose av Chlamydia-infeksjoner
NO20053860D0 (no) COP 1 for behandling av inflammatorisk tarmsykdom.
DK2224012T3 (da) Sammensætninger og fremgangsmåder til terapi og diagnose af inflammatoriske tarmsygdomme
AU2001289617A1 (en) Diagnosis of diseases associated with signal transduction
NO20032007D0 (no) Radiofarmasöytiske midler for diagnose av Alzheimer's sykdom
NO20015180D0 (no) Analyse av fundusbilder
NO20031443D0 (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
DE602004028071D1 (de) Halter - Anordnung für eine medizinische Naddle
ATE258035T1 (de) Wegwerfartikel für menschliche fäkalien
ID26097A (id) Proses pembuatan pakaian luar sekali pakai
IL141950A0 (en) Diagnosis of prion diseases
FR2845267B1 (fr) Kit cutane de diagnostic de l'atopie
FR2822955B1 (fr) Methode de diagnostic de maladies inflammatoires chroniques de l'intestin
DE60122601D1 (de) Behandlung von entzündlichen Darmerkrankungen
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO20021355L (no) Forbedret diagnostisk metode for detektering av dysplastisk epitelialvev
DE60014888D1 (de) Wegwerfgewebe fühlerspitze
AU4962001A (en) Diagnosis of autoimmune disease
AU2002350975A8 (en) Diagnosis of inflammatory bowel disease
IT1314663B1 (it) Tester diagnosi

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

MK1K Patent expired